Related Experiment Video
Updated: Dec 1, 2025
09:30
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
3.4K
Genomic Inverse PCR for Screening of Preleukemic Cells in Newborns (GIPFEL Technology)
Daniel Hein1, Arndt Borkhardt2, Ute Fischer2
1Department of Pediatric Oncology, Hematology and Clinical Immunology, University Children's Hospital Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany. daniel.hein@med.uni-duesseldorf.de.
Methods in Molecular Biology (Clifton, N.J.)
|November 9, 2020
Summary
Genomic inverse PCR for exploration of ligated breakpoints (GIPFEL) offers a more reliable method for detecting childhood leukemia genetic subtypes. This DNA-based technique overcomes the limitations of RNA-based reverse transcriptase PCR.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- Recurrent chromosomal translocations are key genetic drivers in childhood leukemia subtypes.
- These translocations initiate the development of preleukemic cell clones.
- Current RNA-based detection methods like reverse transcriptase PCR have significant limitations.
Purpose of the Study:
- To introduce a novel DNA-based method for detecting chromosomal translocations.
- To overcome the drawbacks associated with RNA-based detection techniques.
- To provide a more robust tool for the genetic subtyping of childhood leukemia.
Main Methods:
- Development and description of the genomic inverse PCR for exploration of ligated breakpoints (GIPFEL) technique.
- Utilizing DNA-level analysis to identify translocation breakpoints.
- Comparison of GIPFEL with existing RNA-based methods.
Main Results:
- GIPFEL demonstrates superior reliability compared to RNA-based methods.
- The technique effectively overcomes issues of RNA instability and contamination sensitivity.
- Successful identification of ligated breakpoints at the DNA level.
Conclusions:
- GIPFEL represents a significant advancement in the detection of genetic alterations in leukemia.
- This method offers a more stable and sensitive approach for diagnosing and subtyping childhood leukemia.
- GIPFEL has the potential to improve diagnostic accuracy and guide treatment strategies.
